Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-16-006001
Filing Date
2016-05-20
Accepted
2016-05-20 11:19:40
Documents
58
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ecte10q_mar312016.htm 10-Q 543119
2 CERTIFICATION ex31-1.htm EX-31.1 12150
3 CERTIFICATION ex31-2.htm EX-31.2 11759
4 CERTIFICATION ex32-1.htm EX-32.1 5041
5 CERTIFICATION ex32-2.htm EX-32.2 5002
  Complete submission text file 0001415889-16-006001.txt   2755745

Data Files

Seq Description Document Type Size
6 ecte-20160331.xml EX-101.INS 433019
7 ecte-20160331.xsd EX-101.SCH 32847
8 ecte-20160331_cal.xml EX-101.CAL 40417
9 ecte-20160331_def.xml EX-101.DEF 101677
10 ecte-20160331_lab.xml EX-101.LAB 248939
11 ecte-20160331_pre.xml EX-101.PRE 191143
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

EIN.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35218 | Film No.: 161665149
SIC: 3845 Electromedical & Electrotherapeutic Apparatus